Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized open-label study of nab-paclitaxel with or without trastuzumab in HER2-negative metastatic breast cancer with HER2-positive circulating tumor cells
2012-005352-41Phase 2Terminated
- Sponsor
- ASST Cremona
- Start
- Mar 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab, paclitaxel in breast cancer, sponsored by ASST Cremona. Started Mar 2014; status: terminated.
02
Drugs
trastuzumabpaclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2012-005352-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005352-41.